AS
PFE icon

Altshuler Shaham’s Pfizer PFE Stock Holding History

Altshuler Shaham’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-99,000
Closed -$344K – 617
2021
Q3 		$344K Buy
+99,000
New +$4.39M ﹤0.01% 212

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Altshuler Shaham's PFE Position: Q2 2026 in Review

Altshuler Shaham opened a new position in Pfizer (PFE) in Q2 2026: 311 shares worth $7.49K. The stake represents ﹤0.01% of the portfolio and ranks #339 among its holdings. This is a return to the name: Altshuler Shaham previously reported a position in PFE as recently as Q1 2024.

Altshuler Shaham first reported a position in PFE in Q4 2017 and has held it in 27 quarters since. The position peaked at $266M in Q2 2023. 2,429 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Altshuler Shaham held 311 shares of Pfizer worth $7.49K as of Q2 2026.
  • Pfizer was a new Altshuler Shaham position in Q2 2026.
  • Pfizer made up ﹤0.01% of Altshuler Shaham's portfolio in Q2 2026, its #339 holding.
  • Altshuler Shaham first reported a position in Pfizer in Q4 2017 and has held it in 27 quarters since.
  • Altshuler Shaham's Pfizer position peaked at $266M in Q2 2023.
  • 2,429 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Altshuler Shaham's 13F filing for Q2 2026, filed 12 Aug 2026.